Journey Medical Corp (DERM)
6.53
+0.24
(+3.82%)
USD |
NASDAQ |
Oct 04, 16:00
6.51
-0.02
(-0.31%)
After-Hours: 20:00
Journey Medical SG&A Expense (Annual): 43.91M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 43.91M |
| December 31, 2022 | 59.47M |
| December 31, 2021 | 39.83M |
| Date | Value |
|---|---|
| December 31, 2020 | 22.09M |
| December 31, 2019 | 19.13M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
19.13M
Minimum
2019
59.47M
Maximum
2022
36.89M
Average
39.83M
Median
2021
SG&A Expense (Annual) Benchmarks
| Fortress Biotech Inc | 94.12M |
| Checkpoint Therapeutics Inc | 8.685M |
| Avenue Therapeutics Inc | 4.179M |
| Eton Pharmaceuticals Inc | 18.93M |
| 4D Molecular Therapeutics Inc | 36.49M |